Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZANUBRUTINIB for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 251 adverse event reports in the FDA FAERS database where ZANUBRUTINIB was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for ZANUBRUTINIB

Side Effect Reports % Deaths Hosp.
Off label use 376 13.4% 43 116
Disease progression 224 8.0% 41 26
Contusion 165 5.9% 3 23
Myelosuppression 147 5.3% 4 68
Fatigue 146 5.2% 13 34
Rash 134 4.8% 5 20
Death 120 4.3% 120 15
White blood cell count decreased 119 4.3% 9 37
Platelet count decreased 112 4.0% 9 37
Anaemia 102 3.7% 11 20
Diarrhoea 101 3.6% 12 22
Pneumonia 100 3.6% 21 55
Covid-19 89 3.2% 17 40
Drug ineffective 87 3.1% 24 27
Asthenia 81 2.9% 10 30

Other Indications for ZANUBRUTINIB

Chronic lymphocytic leukaemia (726) Waldenstrom's macroglobulinaemia (429) Product used for unknown indication (418) Mantle cell lymphoma (329) Marginal zone lymphoma (97) B-cell small lymphocytic lymphoma (74) B-cell lymphoma (73) Follicular lymphoma (68) Lymphoma (64) Non-hodgkin's lymphoma (62)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

ZANUBRUTINIB Full Profile All Diffuse large b-cell lymphoma Drugs ZANUBRUTINIB Demographics ZANUBRUTINIB Timeline